Millstone Evans Group, LLC Maravai Lifesciences Holdings, Inc. Transaction History
Millstone Evans Group, LLC
- $147 Billion
- Q4 2024
A detailed history of Millstone Evans Group, LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Millstone Evans Group, LLC holds 162 shares of MRVI stock, worth $696. This represents 0.0% of its overall portfolio holdings.
Number of Shares
162Holding current value
$696% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MRVI
# of Institutions
225Shares Held
140MCall Options Held
237KPut Options Held
19.4K-
Gtcr LLC20.2MShares$86.6 Million13.05% of portfolio
-
12 West Capital Management LP New York, NY14MShares$60.2 Million12.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$50.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$41.8 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.35MShares$35.9 Million1.97% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $566M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...